CXCL8 and neoplasm: Emerging evidence indicates that CXCL8 plays a critical regulatory role in the TME, contributing to tumor progression and metastasis, and can directly promote resistance to chemotherapy, targeted therapies, and immune checkpoint inhibitors (ICIs)22–25.